Related Experiment Video
Updated: May 14, 2026
04:42
Micro-scale Engineering for Cell Biology
Published on: October 1, 2007
Looking at Biotech's Crystal Ball: The issues we'll be focused on in 2005
Biotechnology Healthcare
|February 8, 2013
Summary
Biotechnology
Area of Science:
- Biotechnology and healthcare industry analysis
Background:
- The biotechnology sector faces critical challenges and opportunities.
- Key variables will shape the industry's trajectory in 2005.
Purpose of the Study:
- To outline the pivotal factors influencing the biotechnology industry's performance in 2005.
- To provide insights into strategic considerations for industry stakeholders.
Main Methods:
- Analysis of five key variables impacting the biotechnology sector.
- Examination of electronic medical records, investment capital, clinician engagement, benefit designs, and product value demonstration.
Main Results:
- Electronic medical records can accelerate data collection.
- Clarifying investment capital sources is crucial for growth.
- Keeping clinicians updated on innovations is essential.
- Benefit designs must adapt to costly new biotech products.
- Demonstrating product value is paramount for market success.
Conclusions:
- Strategic focus on these five variables is necessary for navigating the evolving biotechnology landscape.
- Proving the value of biotechnology products is the most critical factor for success in 2005.
Related Concept Videos
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.